BIOMAT Database Logo BIOMAT Database Logo

Kinin and myocardial infarction: effect of Trasylol on the plasma prekallikrein and kallikrein inhibitor. 1978

P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D007704 Kininogens Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN. Cystatins, Kininogen,Kininogen,Prekinins,Prokinins,T-Kininogen,Thiostatin,Kininogen Cystatins,T Kininogen
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011288 Prekallikrein A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease. Fletcher Factor,Plasma Prokallikrein,Kallikreinogen,Plasma Prokallikrein A,Factor, Fletcher,Prokallikrein A, Plasma,Prokallikrein, Plasma
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin.
May 1984, Clinical science (London, England : 1979),
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
The kallikrein-kinin system in post-myocardial infarction cardiac remodeling.
August 1997, The American journal of cardiology,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
[Effect of kinin hormones on the gastric juice secretion. IV. Effect of proteinase inhibitor Trasylol].
March 1971, Medizinische Klinik,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Effect of aprotinin and C1-esterase inhibitor on activation of the plasma kallikrein-kinin system in vivo.
January 1987, Progress in clinical and biological research,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
January 1968, Transactions of the Association of American Physicians,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
September 2007, Journal of cardiac failure,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Effect of Neurotropin on the activation of the plasma kallikrein-kinin system.
March 1992, Biochemical pharmacology,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Aprotinin in acute pancreatitis: effect on the plasma kallikrein-kinin system.
January 1982, Acta medica Scandinavica. Supplementum,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
Effect of the proteinase inhibitor Trasylol on the mortality and infarct size in dogs with acute myocardial infarction.
January 1977, Pharmacological research communications,
P L Del Bianco, and G Franchi, and M Lombardi, and D Caleri, and C Curradi, and F Sicuteri
The plasma kinin system in acute myocardial infarction.
January 1978, Acta medica Scandinavica. Supplementum,
Copied contents to your clipboard!